Cellarity is a first-of-its-kind therapeutics company that is discovering and developing medicines by studying and altering cell behaviors. Cellarity has developed a powerful, generalizable platform harnessing single-cell technologies and machine learning to unveil the network state of a given cell, defining the cell's behavior. Cellarity's platform digitizes and quantifies cellular behaviors, unravels the network dynamics that govern those behaviors, and generates medicines that can direct them. These medicines are rationally designed to alter the cell behaviors that drive disease, obviating the need for lengthy and costly high throughput screening.
With the unique ability to discover drugs based on cellular behavior, Cellarity’s goal is to dramatically increase the success rate and speed of drug discovery.